PMID: 6412861Sep 24, 1983Paper

Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus

British Medical Journal
J R BakerR N Johnson

Abstract

Fructosamine, a putative measure of serum glycosylated proteins, was measured in 74 subjects referred for oral glucose tolerance tests. A normal range (mean (2 SD] of 1.6 (0.4) mmol/l (40(10) mg/100 ml) derive from results obtained in 83 healthy non-diabetic volunteers permitted the detection of 15 out of 17 (88%) subjects with proved diabetes and yielded only five (9%) false positive diagnoses. Fructosamine concentrations correlated significantly (p less than 0.001) with fasting plasma glucose concentrations (r = 0.76) and glycosylated haemoglobin concentrations (r = 0.70). A longitudinal study suggested that fructosamine concentration was an index of intermediate term (one to three weeks) blood glucose control. Fructosamine concentration was not related to uraemia and did not depend on albumin or total protein concentrations, provided that serum albumin concentrations remained above 30 g/l. Estimation of fructosamine concentrations is a fully automated procedure and may provide a simple means of screening for diabetes mellitus.

References

Nov 6, 1976·Lancet·R J Jarrett, H Keen
Sep 1, 1978·The Journal of Clinical Endocrinology and Metabolism·J V SantiagoF Fisher
Sep 1, 1979·Annals of Internal Medicine·P J DunnR E Gleason
Oct 1, 1975·Journal of Clinical Pathology·R J Holt
May 1, 1966·Journal of Atherosclerosis Research·D F BrownJ T Doyle
Jan 7, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·R N JohnsonJ R Baker
Jun 1, 1980·Diabetes·R Dolhofer, O H Wieland
Jul 1, 1981·Annals of Internal Medicine·A L Kennedy, T J Merimee
Nov 15, 1980·British Medical Journal
Jan 1, 1980·Diabetologia·H FragM M Müller
Feb 1, 1981·The American Journal of Medicine·H F Bunn

❮ Previous
Next ❯

Citations

Feb 1, 1993·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·F GinevriR Gusmano
Jan 1, 1988·Acta diabetologica latina·M R AvernaA Notarbartolo
Apr 1, 1990·Acta diabetologica latina·M A AjabnoorZ M Marzouki
Apr 30, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·S W WalkerA F Smith
Apr 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·R N JohnsonJ R Baker
Sep 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·D MacDonaldR Swaminathan
Jul 15, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·H C FordM J Crooke
Jul 15, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·P JerntorpJ O Jeppsson
Apr 15, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·P E SenécalR Coulombe
Jun 30, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·M H DominiczakW E Finlay
May 31, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·S M MacRuryM H Dominiczak
Dec 31, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·M P MontagnaM L Castellana
Dec 16, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·S Rodríguez-SegadeR Del Río
Oct 1, 1988·Clinical Biochemistry·G GlikmanasA Truchaud
Aug 1, 1989·Clinical Biochemistry·F DesjarlaisG Letellier
Dec 3, 1983·Lancet·J S Yudkin, M de Swiet
May 1, 1997·Diabetes Research and Clinical Practice·J P FreitasF G Rodrigo
Oct 6, 1997·Endocrinology and Metabolism Clinics of North America·D E Goldstein, R R Little
Jul 27, 2001·Diabetes Technology & Therapeutics·M C Riddle
Jul 27, 2001·Diabetes Technology & Therapeutics·D C Klonoff
Dec 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·J E HoweyC G Fraser
Jul 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·H R HenrichsE Vorberg
Mar 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·V J ParfittM Hartog
Jan 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·D A RobertsonH Gareeboo
Jan 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·M S ArdawiA A Bahnassy
Aug 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·P F HughesJ Morrison
Apr 1, 1988·Archives of Disease in Childhood·J Allgrove, B L Cockrill
Nov 1, 1994·Archives of Disease in Childhood·J P ShieldC A Pennock
Sep 4, 2004·Environmental Health Perspectives·Gaku IchiharaYasuhiro Takeuchi
Feb 2, 2013·PloS One·Wahyu WulaningsihMieke Van Hemelrijck
Jan 29, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marijn SpeeckaertUNKNOWN European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD
Apr 1, 1989·The American Journal of the Medical Sciences·W T CefaluK Macaulay
May 1, 1986·American Journal of Obstetrics and Gynecology·A B Roberts, J R Baker
Jul 1, 1988·American Journal of Obstetrics and Gynecology·A B RobertsP Henley
Mar 1, 1989·American Journal of Obstetrics and Gynecology·R ComtoisH Beauregard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.